IMPORTANT SAFETY INFORMATION: Children, adolescents, and young adults taking antidepressants for Major Depressive Disorder (MDD) and other psychiatric disorders are at an increased risk of suicidal thinking and behavior. More

IMPORTANT SAFETY INFORMATION for ABILIFY:U.S. FULL PRESCRIBING INFORMATION, including Boxed WARNING, and Medication Guide.
Antidepressants may increase suicidal thoughts or behaviors in some children, teenagers,
and young adults, especially within the first few months of treatment or when the dose is changed.
Depression and other serious mental illnesses are themselves associated with an increase in the risk of suicide.
Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms,
unusual changes in behavior, or thoughts of suicide. Such symptoms should be reported to the patient's healthcare
provider right away, especially if they are severe or occur suddenly. ABILIFY® (aripiprazole)
is not approved for use in pediatric patients with depression.
See More Safety Information

Pay as little as $5 a month for brand-name ABILIFY

By doing so, you agree that you have a prescription for ABILIFY, commercial insurance, and are between the ages of 18 and 64. Conditions apply.

The ABILIFY Savings Card Program

Get more out of your savings card by signing up for the program after you download your card.

What is ABILIFY for?

ABILIFY (aripiprazole) is prescribed for:

Use as an add-on treatment for adults with depression when an antidepressant alone
is not enough

Treatment of manic or mixed episodes associated with bipolar I disorder in adults
and in pediatric patients 10 to 17 years of age

Treatment of schizophrenia in adults and in adolescents 13 to 17 years of age

Treatment of irritability associated with autistic disorder in pediatric patients
6 to 17 years of age

Check this box to download the savings card.

By doing so, you agree that you have a prescription for ABILIFY, commercial insurance, and are between the ages of 18 and 64. Conditions apply.

The ABILIFY Savings Card Program

Get more out of your savings card by signing up for the program after you download your card.

3 Steps to Saving

Watch and learn how you can save on brand-name ABILIFY.

Savings Card FAQs

Learn the answers to questions about program details, how to get started, and more.

For patients between the ages of 6 and 17, an adult must use the card on their behalf.

Patients are not eligible for the ABILIFY Savings Card if their prescriptions are covered in whole or in part by any state or federally funded programs, including, but not limited to, Medicare or Medicaid (including Medicaid managed care), Medigap, VA, FEHB, DOD, or TRICARE. Only valid in the U.S. and Puerto Rico, but not for residents of Massachusetts or where otherwise prohibited by law. Offer void where prohibited by law, taxed, or restricted. Other restrictions may apply.

For more information about the ABILIFY Savings Card, call
1-855-427-74701-855-427-7470
from 8 am to 7 pm ET, Monday through Friday.

IMPORTANT SAFETY INFORMATION and INDICATIONS for
ABILIFY® (aripiprazole)
Elderly people with psychosis related to dementia (for example, an inability to
perform daily activities as a result of increased memory loss), treated with antipsychotic
medicines including ABILIFY (aripiprazole), are at an increased risk of death compared to placebo. ABILIFY (aripiprazole)
is not approved for the treatment of people with dementia-related psychosis (see
Boxed WARNING).

Antidepressants may increase suicidal thoughts or behaviors in some children,
teenagers, and young adults, especially within the first few months of treatment
or when the dose is changed. Depression and other serious mental illnesses are themselves
associated with an increase in the risk of suicide. Patients on antidepressants
and their families or caregivers should watch for new or worsening depression symptoms,
unusual changes in behavior, or thoughts of suicide. Such symptoms should be reported
to the patient’s healthcare provider right away, especially if they are severe or
occur suddenly.
ABILIFY (aripiprazole)
is not approved for use in pediatric patients with depression (see Boxed WARNING).

Contraindication: Patients should not use
ABILIFY (aripiprazole)
if they are allergic to aripiprazole or any of the ingredients in
ABILIFY (aripiprazole). Allergic reactions have ranged from rash, hives and itching to anaphylaxis, which
may include difficulty breathing, tightness in the chest, and swelling of the mouth,
face, lips, or tongue.

Serious side effects may include:

An increased risk of stroke and ministroke have been reported in
clinical studies of elderly people with dementia-related psychosis

High fever, stiff muscles, confusion, sweating, changes in pulse, heart rate and
blood pressure may be signs of a condition called neuroleptic malignant syndrome
(NMS), a rare and serious condition that can lead to death

Increases in blood sugar levels (hyperglycemia) can happen in some
people who take
ABILIFY (aripiprazole). Extremely high blood sugar can lead to coma or death. If you have diabetes,
or risk factors (for example, obesity, family history of diabetes), or have the
following symptoms: increases in thirst, urination, or hunger, feel weak or tired,
sick to your stomach, or confused (or breath smells fruity), your blood sugar should
be monitored

Changes in cholesterol and triglyceride (fat, also called
lipids) levels in the blood have been seen in patients taking medicines
like
ABILIFY (aripiprazole)

Weight gain has been reported in patients taking medicines like
ABILIFY (aripiprazole)
so your weight should be checked regularly. Weight gain in children (ages 6 to 17)
should be compared against that expected with normal growth

ABILIFY (aripiprazole)
and medicines like it have been associated with difficulty swallowing
which may lead to aspiration or choking

Uncontrollable movements of face, tongue, or other parts of body, as these may be
signs of a serious condition called tardive dyskinesia (TD). TD
may not go away, even if you stop taking
ABILIFY (aripiprazole). TD may also start after you stop taking
ABILIFY (aripiprazole)

Orthostatic hypotension (decreased blood pressure) or lightheadedness
or fainting when rising too quickly from a sitting or lying position has been reported
with
ABILIFY (aripiprazole)

Decreases in white blood cells (WBC; infection fighting cells) have been reported
in some patients taking
ABILIFY (aripiprazole).
Patients with a history of a significant decrease in WBC count or who have experienced
a low WBC count due to drug therapy should have their blood tested and monitored
during the first few months
of therapy

Seizures (convulsions) have been reported with
ABILIFY (aripiprazole). Tell your healthcare provider if you have a history of or are at risk for seizures

ABILIFY (aripiprazole)
and medicines like it can affect your judgment, thinking, or motor skills. You should
not drive or operate hazardous machinery until you know how
ABILIFY (aripiprazole)
affects you

Medicines like
ABILIFY (aripiprazole)
can impact your body’s ability to reduce body temperature; you should avoid overheating
and dehydration

Tell your healthcare provider if you are pregnant or intend to become pregnant.
Also tell your healthcare provider about any other medical conditions you have and
about all prescription and non-prescription medicines you are taking or plan to
take since there are some risks for drug interactions

While taking
ABILIFY (aripiprazole), avoid:

Drinking alcohol

Breast-feeding an infant

Most common side effects (≥10%) from all clinical trials involving adults or pediatric
patients include:

Use as an add-on treatment to an antidepressant for adults with Major Depressive
Disorder who have had an inadequate response to antidepressant therapy

Treatment of manic or mixed episodes associated with Bipolar I Disorder in adults
and in pediatric patients 10 to 17 years of age

Treatment of Schizophrenia in adults and in adolescents 13 to 17 years of age

Treatment of irritability associated with Autistic Disorder in pediatric patients
6 to 17 years of age

Treatment of Tourette’s Disorder in pediatric patients 6 to 18 years of age

Special Considerations for Pediatric Uses:

Discuss the risks and benefits of treatment with your child’s healthcare provider.
Treatment should be started only after a thorough diagnostic evaluation and as part
of a total treatment program

IMPORTANT SAFETY INFORMATION
Elderly people with psychosis related to dementia (for example, an inability to
perform daily activities as a result of increased memory loss), treated with antipsychotic
medicines including ABILIFY (aripiprazole), are at an increased risk of death compared to placebo. ABILIFY (aripiprazole)
is not approved for the treatment of people with dementia-related psychosis (see
Boxed WARNING).

Antidepressants may increase suicidal thoughts or behaviors in some children,
teenagers, and young adults, especially within the first few months of treatment
or when the dose is changed. Depression and other serious mental illnesses are themselves
associated with an increase in the risk of suicide. Patients on antidepressants
and their families or caregivers should watch for new or worsening depression symptoms,
unusual changes in behavior, or thoughts of suicide. Such symptoms should be reported
to the patient’s healthcare provider right away, especially if they are severe or
occur suddenly.
ABILIFY (aripiprazole)
is not approved for use in pediatric patients with depression (see Boxed WARNING).

Contraindication: Patients should not use
ABILIFY (aripiprazole)
if they are allergic to aripiprazole or any of the ingredients in
ABILIFY (aripiprazole). Allergic reactions have ranged from rash, hives and itching to anaphylaxis, which
may include difficulty breathing, tightness in the chest, and swelling of the mouth,
face, lips, or tongue.

Serious side effects may include:

An increased risk of stroke and ministroke have been reported in
clinical studies of elderly people with dementia-related psychosis

High fever, stiff muscles, confusion, sweating, changes in pulse, heart rate and
blood pressure may be signs of a condition called neuroleptic malignant syndrome
(NMS), a rare and serious condition that can lead to death

Increases in blood sugar levels (hyperglycemia) can happen in some
people who take
ABILIFY (aripiprazole). Extremely high blood sugar can lead to coma or death. If you have diabetes,
or risk factors (for example, obesity, family history of diabetes), or have the
following symptoms: increases in thirst, urination, or hunger, feel weak or tired,
sick to your stomach, or confused (or breath smells fruity), your blood sugar should
be monitored

Changes in cholesterol and triglyceride (fat, also called
lipids) levels in the blood have been seen in patients taking medicines
like
ABILIFY (aripiprazole)

Weight gain has been reported in patients taking medicines like
ABILIFY (aripiprazole)
so your weight should be checked regularly. Weight gain in children (ages 6 to 17)
should be compared against that expected with normal growth

ABILIFY (aripiprazole)
and medicines like it have been associated with difficulty swallowing
which may lead to aspiration or choking

Uncontrollable movements of face, tongue, or other parts of body, as these may be
signs of a serious condition called tardive dyskinesia (TD). TD
may not go away, even if you stop taking
ABILIFY (aripiprazole). TD may also start after you stop taking
ABILIFY (aripiprazole)

Orthostatic hypotension (decreased blood pressure) or lightheadedness
or fainting when rising too quickly from a sitting or lying position has been reported
with
ABILIFY (aripiprazole)

Decreases in white blood cells (WBC; infection fighting cells) have been reported
in some patients taking
ABILIFY (aripiprazole).
Patients with a history of a significant decrease in WBC count or who have experienced
a low WBC count due to drug therapy should have their blood tested and monitored
during the first few months
of therapy

Seizures (convulsions) have been reported with
ABILIFY (aripiprazole). Tell your healthcare provider if you have a history of or are at risk for seizures

ABILIFY (aripiprazole)
and medicines like it can affect your judgment, thinking, or motor skills. You should
not drive or operate hazardous machinery until you know how
ABILIFY (aripiprazole)
affects you

Medicines like
ABILIFY (aripiprazole)
can impact your body’s ability to reduce body temperature; you should avoid overheating
and dehydration

Tell your healthcare provider if you are pregnant or intend to become pregnant.
Also tell your healthcare provider about any other medical conditions you have and
about all prescription and non-prescription medicines you are taking or plan to
take since there are some risks for drug interactions

While taking
ABILIFY (aripiprazole), avoid:

Drinking alcohol

Breast-feeding an infant

Most common side effects (≥10%) from all clinical trials involving adults or pediatric
patients include:

Terms and Conditions

With this Savings Card, eligible, commercially insured patients can save on their out-of-pocket costs and pay as little as $5 per co-pay for
their ABILIFY® (aripiprazole) prescriptions. When the co-pay for a 30-day supply is above $5, all eligible, commercially insured patients will pay the first $5, total benefit not to exceed the list price, as determined by Otsuka America Pharmaceutical, Inc. (OAPI) and communicated to your pharmacy. 60- and 90-day dispenses are permissible within the terms of the program. This card must be activated by calling 1-888-922-45431-888-922-4543. You can continue to use this card for as long as you are eligible or until this program is terminated. (Limit 1 card per patient.) The card is not transferable. Patients are not eligible if they are 65 years of age and older; pay cash for their prescriptions; or are covered in whole or in part by any state or federally funded programs, including, but not limited to, Medicare or
Medicaid (including Medicaid managed care), Medigap, VA, FEHB, DOD, or TRICARE. Only valid in U.S. and Puerto Rico, but not for residents of
Massachusetts or where otherwise prohibited by law. Offer void where prohibited by law, taxed, or restricted. Other conditions may apply.

To receive the benefits of this program, you must present the Savings Card to your pharmacist along with a valid ABILIFY prescription. This program is not health insurance. OAPI has the right to rescind, revoke, or amend this program without notice. Your participation in this program confirms that this offer is consistent with your insurance coverage and that you will report the value received if required by your insurance provider. When you use this card, you are certifying that you understand and will comply with the program rules, terms, and conditions. For questions, please call 1-888-9-ABILIFY(1-888-922-4543)(1-888-922-4543) 8 am-7 pm ET, Monday-Friday.

Notice to the pharmacy: When you use this card, you are certifying that you have not submitted and will not submit a claim for reimbursement under any federal, state, or other governmental programs for this prescription. As a condition of payment, you certify that you are in compliance with all program rules, terms, and conditions, as well as with any obligations to provide notice of your participation in this program to third-party payers as required by law, contract, or otherwise.

If primary coverage exists, input card information as secondary coverage and transmit using the COB fields with other coverage code type 08 of the NCPDP transaction. Applicable discounts will be displayed in the transaction response

For pharmacy assistance filing this claim, please call the Pharmacy Help Desk at 1-800-510-48361-800-510-4836